Download REFERENCES 1. Magill SS, Edwards JR, Bamberg W, et al

REFERENCES
1.
Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health careassociated infections. N Engl J Med. 2014;370:1198-208.
2. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US
hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin
Infect Dis. 2004;39:309-317.
3. Arendrup, Maiken C. Epidemiology of invasive candidiasis. Curr Opin Crit Care. 2010;
16:445-452.
4. Kullberg BJ, Arendrup MC. Invasive Candidiasis. N Engl J Med. 2015;373:1445-1456.
5. Cuenca-Estmella, M, et al. Verweij PE, Arendrup MC, et al; SCMID Fungal Infection Study
Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012:
diagnostic procedures. Clin Microbiol Infect. 2012;7:9-18.
6. Pini P, Bettua C, Orsi C. Evaluation of serum (1 → 3)-β-d-glucan clinical performance: kinetic
assessment, comparison with galactomannan and evaluation of confounding factors.
Infection. 2015 Oct 16. [Epub ahead of print]
7. Mylonakis E, Clancy CJ, Ostrosky-Zeichner L, et al. T2 Magnetic Resonance Assay for the
Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial. Clin Infect Dis. 2015;60:892899.
8. Lefort A, Chartier L, Sendid B, et al. Diagnosis, management and outcome of Candida
endocarditis. Clin Microbiol Infect. 2012;18:e99-e109.
9. Andes DR, Safdar N, Baddley JW, et al; the Mycoses Study Group. Impact of treatment
strategy on outcomes in patients with candidemia and other forms of invasive Candidiasis: a
patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54:1110-1122.
10. Pappas PG, Kaufmann CA, Andes D, et al. Clinical Practice guidelines for the management of
candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis.
2009;48:503-535.
11. Reboli AC, Rotstein C, PG Pappas, et al. Anidulafungin versus fluconazole for invasive
candidiasis. N Engl J Med. 2007;356:2472-2482.
12. Nguyen MH, Peacock JE Jr, Tanner DC, et al. Therapeutic approaches in patients with
candidemia: evaluation in a multicenter, prospective, observational study. Arch Intern Med.
1995;155:2429-2435.
13. Nucci M, Anaissie E. Revisiting the source of candidemia: skin or gut? Clin Infect Dis.
2001;33:1959-1967.
14. Nucci M, Anaissie E, Betts RF, et al. Early removal of central venous catheter in patients
with candidemia does not improve outcome: analysis of 842 patients from 2 randomized
clinical trials. Clin Infect Dis 2010; 51:295-303.
15. S Kucharikova, H Tournu, M Holtappels, et al. In vivo efficacy of anidulafungin against
mature Candida albicans biofilms in a novel rat model of catheter-associated candidiasis.
Antimicrob Agents Chemother. 2010;54:4474-4475.
16. Kuhn DM, George T, Chandra J, et al. Antifungal susceptibility of Candida biofilms: unique
efficacy of amphotericin b lipid formulations and echinocandins. Antimicrob Agents
Chemother. 2002;46:1773-1780.
17. Oude Lashof AM, Rothova A, Sobel JD, et al. Ocular manifestations of candidemia. Clin Infect
Dis. 2011;53:262-268.
18. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with
amphotericin b for the treatment of candidemia in patients without neutropenia.
Candidemia study group and the national institute. N Engl J Med. 1994;331:1325-1330.
19. Bullberg BJ, Sobel JD, Ruhnke M, et al. Voriconazole versus a regimen of amphotericin b
followed by fluconazole for candidaemia in non-neutropenic patients: a randomized noninferiority trial. Lancet. 2005;366:1435-1442.
20. Paramythiotou E, Frantzeskaki F, Flevari A, et al. Invasive fungal infections in the ICU: how
to approach, how to treat. Molecules. 2014;19:1085-1119.
21. Edwards JE. Candida species. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and
Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, PA: Elsevier
Saunders; 2015:2879-2894.
22. Alvarez-Lerma F, Nolla-Salas J, León C, et al. Candiduria in critically ill patients admitted to
intensive care medical units. Intensive Care Med. 2003;29:1069-1076.
23. Simpson C, Blitz S, Shafran SD. The effect of current management on morbidity and
mortality in hospitalized adults with funguria. J Infect. 2004;49:248-252.
24. Paul N, Mathai E, Abraham OC, et al. Factors associated with candiduria and related
mortality. J Infect. 2007;55:450-455.
25. Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of
funguria in hospitalized patients. The national institute for allergy and infectious diseases
(NIAID) mycoses study group. Clin Infect Dis. 2000;30:14-18.
26. Bougnoux ME, Kac G, Aegerter P, et al. Candidemia and candiduria in critically ill patients
admitted to intensive care units in France: Incidence, molecular diversity and outcome.
Intensive Care Med. 2008;34:292-299.
27. Binelli CA, Moretti ML, Assis RS, et al. Investigation of the possible association between
nosocomial candiduria and candidemia. Clin Microbiol Infect. 2006;12:538-543.
28. Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin
North Am. 2014;28:61-74.
29. Meersseman W, Lagrou K, Spriet I, et al. Significance of the isolation of candida species from
airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med.
2009;35:1526-1531.
30. Pappas P, Kaufmann C, Andes D, et al. Clinical practice guideline for the management of
candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis.
2016;62:e1-e50.